American Journal of Clinical Nutrition, Vol 66, 1581S-1586S, Copyright © 1997 by The American Society for Clinical Nutrition, Inc

REVIEW ARTICLES

Human studies on the effects of fatty acids on cancer: summary, gaps, and future research

JT Dwyer
Tufts University School of Medicine, New England Medical Center, Boston, MA 02111, USA. johanna.dwyer@es.nemc.org

Both the goal of understanding the basic biology of cancer development as well as the practical considerations involving public health, marketing, and nutrition education have stimulated interest on the effects of individual fatty acids on cancer. Data on diet-disease relations must meet the standard of significant scientific agreement based on the totality of publicly available scientific evidence. The process of arriving at significant scientific agreement begins by collecting data accumulated from epidemiologic associations, animal studies, and clinical trials. This supplement represents one useful effort toward that end. Questions raised include: 1) What stage of the disease is being studied, what are the relevant characteristics of the study participants, how well characterized was the diet, and were appropriate experimental designs used; 2) Is there is a significant role for markers of disease and, if so, are the markers available; 3) Is there consistency, strength, and quality of evidence for establishing basic scientific relations; 4) Do dose-response relations, biological plausibility, and temporal relations (with special attention to clinical trials) exist; 5) What is the level of specificity of the data for the health claim or posited relation; and 6) What are the effective amounts of fatty acids in foods and diet? More complete food- composition data with respect to fatty acids and more comprehensive food tables are needed, as are better methods for measuring fat intakes, better markers of progression, and more definitive epidemiologic and clinical studies. At present there is insufficient evidence to conclude that specific fatty acids are associated with cancer development in humans.

This article has been cited by other articles:

				J. A. Menendez, L. Vellon, R. Colomer, and R. Lupu Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (HerceptinTM) in breast cancer cells with Her-2/neu oncogene amplification Ann. Onc., March 1, 2005; 16(3): 359 - 371. [Abstract] [Full Text] [PDF]

				M. F Leitzmann, M. J Stampfer, D. S Michaud, K. Augustsson, G. C Colditz, W. C Willett, and E. L Giovannucci Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer Am. J. Clinical Nutrition, July 1, 2004; 80(1): 204 - 216. [Abstract] [Full Text] [PDF]

				P. D Terry, T. E Rohan, and A. Wolk Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence Am. J. Clinical Nutrition, March 1, 2003; 77(3): 532 - 543. [Abstract] [Full Text] [PDF]

				S. Hardy, Y. Langelier, and M. Prentki Oleate Activates Phosphatidylinositol 3-Kinase and Promotes Proliferation and Reduces Apoptosis of MDA-MB-231 Breast Cancer Cells, Whereas Palmitate Has Opposite Effects1 Cancer Res., November 1, 2000; 60(22): 6353 - 6358. [Abstract] [Full Text]

				E. Velie, M. Kulldorff, C. Schairer, G. Block, D. Albanes, and A. Schatzkin Dietary Fat, Fat Subtypes, and Breast Cancer in Postmenopausal Women: a Prospective Cohort Study J Natl Cancer Inst, May 17, 2000; 92(10): 833 - 839. [Abstract] [Full Text] [PDF]